Unusual muscle disease in HIV infected patients

Sexually Transmitted Infections

Volumn 80, Issue 4, 2004, Pages 315-317

  Roedling, S ^a   Pearl, D ^a   Manji, H ^b   Hanna, M G ^b   Holton, J L ^b   Miller, R F ^a,c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD8 ANTIGEN; CREATINE KINASE; DIDANOSINE; LAMIVUDINE; LOPINAVIR; NELFINAVIR; RITONAVIR; ZIDOVUDINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LABORATORY TEST; LUMBAR PUNCTURE; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; NERVE CONDUCTION; POLYMYOSITIS; PRIORITY JOURNAL; RADIODIAGNOSIS; TREATMENT OUTCOME; VIRUS LOAD;

ANTI-HIV AGENTS; BIOPSY; CD8-POSITIVE T-LYMPHOCYTES; CREATINE KINASE; DIAGNOSIS, DIFFERENTIAL; DIDANOSINE; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOCYTOSIS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; POLYMYOSITIS;

EID: 4043050866     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2003.008474     Document Type: Article

References (20)

1. Illa I, Nath A, Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol 1991;29:474-81.
2. Johnson RW, Williams FM, Kazi S, et al. Human immunodeficiency virus-associated polymyositis: longitudinal study of outcome. Arthritis Rheum 2003;49:172-8.
3. Medina DJ, Tsai C-H, Hsiung GD, et al. Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides. Antimicrob Agents Chemother 1994;38:1824-8.
4. Martin JL, Brown CE, Matthews-Davis N, et al. Effects of antiviral nucleoside analogues on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother 1994;38:2743-9.
5. Gherardi R, Baudrimont M, Lionnet F, et al. Skeletal muscle toxoplasmosis in patients with acquired immunodeficiency syndrome; a clinical and pathological study. Ann Neurol 1992;32:535-52.
6. Chevalier X, Amoura Z, Viard JP, et al. Muscle lymphoma in patients with AIDS: a diagnostic problem with pyomyositis. Arthritis Rheum 1993;36:426-7.
7. Gherardi R, Belec L, Mhiri C, et al. The spectrum of vasculitis in human immunodeficiency virus-infected patients: a clinicopothologic evaluation. Arthritis Rheum 1993;36:1164-74.
8. Chariot P, Ruet E, Authier FJ, et al. Acute rhabdomyolysis in patients infected by human immunodeficiency virus. Neurology 1994;44:1692-6.
9. Manfredi RA, Motta RB, Patrono DB, et al. A prospective survey of laboratory markers of skeletal muscle damage during HIV disease and antiretroviral therapy. AIDS 2002;16:1969-71.
10. Simpson DM, Katzenstein DA, Hughes MD, et al. Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS 1998;12:2425-32.
11. Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin Arthritis Rheum 2000;30:147-66.
12. Itescu S, Braacato LJ, Buxbaum J, et al. A diffuse CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med 1989;112:3-10.
13. Kazi S, Cohen PR, Williams F, et al. The diffuse infiltrative lymphocytosis syndrome: clinical and immunogenetic features in 35 patients. AIDS 1996;10:385-91.
14. Bocanegra TS, Vasey FB. Musculoskeletal syndromes in parasitic diseases. Clin Rheum Dis N Am 1993;19:505-13.
15. Abrams DI, Goldman AI, Launer C, et al. A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. N Engl J Med 1994;330:657-62.
16. Kieburtz KD, Seidlin M, Lambert JS, et al. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideodyinosine. J Acquir Immune Defic Syndr 1992;5:60-4.
17. Miller RF, Shahmanesn M, Hanna MG, et al. Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors. Antiviral Ther 2003;8:253-7.
18. Benbrick E, Chariot P, Bonavaud S, Ammi-Said M, et al. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddl) and zalcitabine (ddC) on cultured human muscle cells. J Neurol Sci 1997;49:19-25.
19. Masini A, Scott C, Calligaro A, et al. Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damage. J Neurol Sci 1999;166:131-40.
20. Doronzo R, Geremia L, Sacilotto G, et al. 2′,3′ dideoxyinosine-induced acute rhabdomyolysis. Clin Neuropathol 1993;12:S45.